SHERRI BROOKS: Open Payments
NPI 1952640229 · RINGGOLD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 30 payments from 9 companies in 2025. Trend: 2023 $250 · 2024 $738 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $218 |
| Lilly USA, LLC | 6 | $106 |
| Novo Nordisk Inc | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| PFIZER INC. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: VRAYLAR, ZEPBOUND, JARDIANCE, GVOKE HYPOPEN, Ozempic, CAPLYTA, QULIPTA, Symbravo.
Industry payments across GA — which companies pay providers there.
